The pandemic’s darkest hour is yet to come | 新冠疫情的至暗时刻尚未到来 - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
FT英语电台

The pandemic’s darkest hour is yet to come
新冠疫情的至暗时刻尚未到来

Fresh lockdowns are needed to slow the rapid spread of new Covid-19 variants and inevitable deaths
需要新的锁定措施来减缓Covid-19变种的迅速传播和不可避免的死亡。
00:00

Those who predicted that 2021 would feel different from 2020 have been proven correct — but not in the way that anyone wanted. Despite the existence of several effective Covid-19 vaccines, the UK, many European countries, the US and Brazil appear headed for their darkest moments in the pandemic.

The number of people testing positive in the UK now routinely exceeds 50,000 a day. Infections are rising in London, the east of England and south-east; they are also plateauing in other regions where rates had been falling. That is despite universities and schools having been closed for the seasonal holidays. A full reopening has been delayed.

The number of people in hospital with Covid-19 is already higher than the April peak. Sir Jeremy Farrar, director of the Wellcome Trust and a pandemic adviser, told me we are past the point at which the NHS is in danger of collapsing; parts are already buckling. Healthcare staff, the same key workers being called on to roll out the vaccines, are exhausted. Many are isolating or sick. The current tiering system is not keeping infections down.

The situation is so grave that a national lockdown, including school closures, looks imperative. “What we’ve got is two or three months now of something that will feel and look and is worse than March and April,” Sir Jeremy says, adding that schools may have to shut into February given the prevalence of the new variant in young people, which risks turning schools into more significant sources of transmission. He emphasised he was speaking in a personal capacity.

The reality is that there is rampant spread, fuelled in the UK by the combination of a new variant that is around 50-70 per cent more transmissible, plus a lifting of restrictions at the beginning of December when the R number was hovering around 1.

A lockdown would starve the virus of the human contact on which it feeds and offer breathing space: to expedite the rollout of vaccines and get ahead of the virus; to get a proper testing regime up and running in schools, so that they can reopen with confidence as the R number falls; and for ministers to display honesty and humility about the immense challenges that still lie ahead. The promise of vaccines should not be a cue for complacency but rather a spur to curb transmission, so that the virus has fewer opportunities to mutate before people can be immunised.

That race between immunisation and mutation has never been more urgent — a fact recognised in the UK’s pragmatic decision to delay booster vaccines so that more people can be given a first dose. A variant with superior transmissibility, even if no more severe than its predecessors, is deeply concerning. The arithmetic of contagion means that more infections, as with the B.1.1.7 strain currently dominating in the UK, inevitably translates into more deaths (despite improvements in therapies and patient care). As well as the personal tragedies that come with increased infections, unrestrained transmission risks brewing further variants that could evade current vaccines. Brazil, India and Mexico are hotspots to watch.

According to the World Health Organization, an even more troubling variant first reported from South Africa has been clocked in at least four other countries, including the UK. This strain, known as 501Y.V2, has already shown some resistance to monoclonal antibodies, a potentially promising treatment. A new variant can arise anywhere and spread everywhere, making the race to conquer coronavirus global not national.

If 2020 taught us anything it is that countries can never act too early and that postponing the inevitable leads to protracted agony. A recent Imperial College London analysis suggests that locking down one week earlier in the first spring wave would have cut UK deaths from around 37,000 to about 16,000.

Taiwan, Vietnam and New Zealand demonstrate that early, aggressive intervention delivers a healthy population able to participate in a healthy economy. Treading a middle way between public health and the economy, as the UK has tried to do since March, is a half-measure that protected neither. It is like trying to keep a motorway open after a pile-up and hoping drivers can swerve to avoid the debris, rather than shutting the road and clearing it so traffic can flow normally. Further collisions simply produce more debris and casualties.

Eventually, the road will have to be shut anyway and take longer to clear. This was the pattern with UK lockdowns in 2020.  Only if we act more swiftly is there a chance 2021 may feel different.

The writer is a science commentator

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

反弹的通胀与不耐烦的特朗普:凯文•沃什面临双重压力

美国参议院本周有望批准这位56岁的金融家接替杰伊•鲍威尔出任美联储主席。

伊朗战争推高燃气价格,印度工人纷纷逃离城市生活

伊朗战争推高了烹饪燃料价格,迫使印度许多务工人员返乡回村。

能源、军火与粮食:特朗普对伊战争日益沉重的代价

这场冲突正波及整个美国经济,造成了数千亿美元的产出损失。

肺纤维化生物科技公司Avalyn Pharma申请首次公开募股(IPO)

一家生物技术公司正开发可吸入剂型的已获批肺纤维化口服药,计划赴公开市场融资以支持其后期研发。
2天前

凯勒拉治疗学公司在生物技术领域创纪录的IPO中融资6.25亿美元

最新的生物科技公司首次公开募股创下历史新高。
2天前

法国将迎来最拥挤的大选角逐场:谁将取代马克龙?

左翼和中间阵营的分裂,助长了极右翼问鼎爱丽舍宫的希望。
设置字号×
最小
较小
默认
较大
最大
分享×